Market Tracker

02/19 1:05pm ET

Novavax Inc (NASDAQ:NVAX)

2.34
Delayed Data
As of Feb 16
 +0.18 / +8.33%
Today’s Change
0.73
Today|||52-Week Range
2.52
+88.71%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close2.16
Today’s open2.27
Day’s range2.20 - 2.52
Volume31,157,977
Average volume (3 months)8,429,396
Market cap$733.9M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.79%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.08-2.03%
AGENAgenus Inc+0.14+3.33%
CRISCuris Inc-0.01-1.37%
EDGEEdge Therapeutics In...+0.05+0.36%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Financial Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts